+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Juvenile Rheumatoid Arthritis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767714
  • Report
  • 116 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • AbbVie Inc
  • Amgen Inc
  • Bristol-Myers Squibb Co
  • Johnson & Johnson
  • Mylan NV
  • MORE
The global clinical trial report- “2019 Juvenile Rheumatoid Arthritis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Juvenile Rheumatoid Arthritis. It presents in-depth analysis of Juvenile Rheumatoid Arthritis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Juvenile Rheumatoid Arthritis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Juvenile Rheumatoid Arthritis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Juvenile Rheumatoid Arthritis

The research work is prepared through extensive and continuous research on Juvenile Rheumatoid Arthritis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Juvenile Rheumatoid Arthritis patients are identified
  • The report includes panorama of Juvenile Rheumatoid Arthritis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Juvenile Rheumatoid Arthritis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • AbbVie Inc
  • Amgen Inc
  • Bristol-Myers Squibb Co
  • Johnson & Johnson
  • Mylan NV
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Juvenile Rheumatoid Arthritis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Juvenile Rheumatoid Arthritis Clinical Trials by Region
2.2.2 Average Enrollment of Juvenile Rheumatoid Arthritis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Juvenile Rheumatoid Arthritis Treatment, 2019

3. Region wise Juvenile Rheumatoid Arthritis Clinical Trials
3.1 Asia Pacific Juvenile Rheumatoid Arthritis Clinical Trials by Country
3.2 Europe Juvenile Rheumatoid Arthritis Clinical Trials by Country
3.3 North America Juvenile Rheumatoid Arthritis Clinical Trials by Country
3.4 Middle East and Africa Juvenile Rheumatoid Arthritis Clinical Trials by Country
3.5 South and Central America Juvenile Rheumatoid Arthritis Clinical Trials by Country

4. Juvenile Rheumatoid Arthritis Clinical Trial Trends
4.1 Start Year wise Juvenile Rheumatoid Arthritis Clinical Trials
4.2 Phase wise Juvenile Rheumatoid Arthritis Clinical Trials
4.3 Trial Status wise Juvenile Rheumatoid Arthritis Clinical Trials
4.4 Trial Type wise Juvenile Rheumatoid Arthritis Clinical Trials

5. Juvenile Rheumatoid Arthritis Average Enrollment Trends
5.1 Average Enrollment in Juvenile Rheumatoid Arthritis Trials by Year
5.2 Average Enrollment in Juvenile Rheumatoid Arthritis Trials by Phase
5.3 Average Enrollment in Juvenile Rheumatoid Arthritis Trials by Status
5.4 Average Enrollment in Juvenile Rheumatoid Arthritis Trials by Type of Trial

6. Companies Participating in Juvenile Rheumatoid Arthritis Clinical Trials
6.1 Juvenile Rheumatoid Arthritis Trials by Sponsor Type
6.2 Juvenile Rheumatoid Arthritis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Juvenile Rheumatoid Arthritis Trials- Phase 1
7.2 Juvenile Rheumatoid Arthritis Trials- Phase 2
7.3 Juvenile Rheumatoid Arthritis Trials- Phase 3
7.4 Juvenile Rheumatoid Arthritis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Juvenile Rheumatoid Arthritis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Juvenile Rheumatoid Arthritis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Juvenile Rheumatoid Arthritis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Juvenile Rheumatoid Arthritis Clinical Trials and Enrolment
Figure 7: North America - Country wise Juvenile Rheumatoid Arthritis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Juvenile Rheumatoid Arthritis Clinical Trials and Enrolment
Figure 9: Juvenile Rheumatoid Arthritis Clinical Trials by Phase
Figure 10: Juvenile Rheumatoid Arthritis Clinical Trials by Trial Status
Figure 11: Juvenile Rheumatoid Arthritis Clinical Trials by Type
Figure 12: Juvenile Rheumatoid Arthritis Clinical Trials by Sponsor Type
Figure 13: Juvenile Rheumatoid Arthritis Clinical Trials by Leading Sponsors
Figure 14: Juvenile Rheumatoid Arthritis Average Enrollment by Phase
Figure 15: Juvenile Rheumatoid Arthritis Average Enrollment by Trial Status
Figure 16: Juvenile Rheumatoid Arthritis Average Enrollment by Type
Figure 17: Juvenile Rheumatoid Arthritis- Average Enrolment by Type of Sponsors
Figure 18: Juvenile Rheumatoid Arthritis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Juvenile Rheumatoid Arthritis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Juvenile Rheumatoid Arthritis Clinical Trials and Enrolment
Table 5: Europe - Country wise Juvenile Rheumatoid Arthritis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Juvenile Rheumatoid Arthritis Clinical Trials and Enrolment
Table 7: North America - Country wise Juvenile Rheumatoid Arthritis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Juvenile Rheumatoid Arthritis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Juvenile Rheumatoid Arthritis Average Enrollment by Phase
Table 15: Juvenile Rheumatoid Arthritis Average Enrollment by Trial Status
Table 16: Juvenile Rheumatoid Arthritis Average Enrollment by Type
Table 17: Juvenile Rheumatoid Arthritis- Average Enrolment by Type of Sponsors
Table 18: Juvenile Rheumatoid Arthritis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • AbbVie Inc
  • Amgen Inc
  • Bristol-Myers Squibb Co
  • C. H. Boehringer Sohn AG & Co KG
  • Johnson & Johnson
  • Mylan NV
  • Novartis AG
  • Parexel International Corp
  • Pfizer Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4767714
Adroll
adroll